Journal
JOURNAL OF NATURAL PRODUCTS
Volume 73, Issue 9, Pages 1578-1581Publisher
AMER CHEMICAL SOC
DOI: 10.1021/np100258e
Keywords
-
Funding
- University of Vienna (Initiative Group Molecular Drug Targets)
- Austrian Federal Ministries of Science and Research (BMWF)
- Health (BMH) [TCM and Age Related Diseases]
- Austrian Science Fund (FWF) [NFN S10704-B03]
Ask authors/readers for more resources
The inhibition of protein tyrosine phosphatase 1B (PTP1B) is of substantial interest for the treatment of type-2 diabetes mellitus. Using an in vitro enzyme assay with human recombinant PTP1B 1,2,3,4,6-penta-O-galloyl-D-glucopyranose (1) was isolated from the roots of Paeonia lactiflora as an inhibitor of PTP1B, with an IC(50) value of 4.8 mu M. Additionally, 1 was shown to act as an insulin sensitizer in human hepatoma cells (HCC-1.2) at a concentration of 10 mu M. Thus, a potential new mechanism of action is provided explaining the antidiabetic properties of P. lactiflora.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available